TIMELINE OF ASSESSMENT The table below shows the Timeline of Minor Applications. HEALTH TECHNOLOGY VASOPRESSIN SAMBONG 250 MG TABLET VARENICLINE NICOTINE REPLACEMENT THERAPY 2.5% PERITONEAL DIALYSIS SOLUTION 0.1% SODIUM HYALURONATE (15 ML) PROPONENT DOH Disease Prevention and Control Bureau Philippine Institute of Traditional and Alternative Health Care (PITAHC) DPCB – Lifestyle-Related Diseases Division DPCB – Lifestyle-Related Diseases continue reading : Minor Applications
Expedited Track (COVID-19 Vaccines)
TIMELINE OF ASSESSMENT The table below shows the Timeline of COVID-19 Vaccines for HTA. PROCESS PEDIA VACCINATION 5 to 11 YRS OLD PEDIA VACCINATION 12 to 17 YRS OLD BOOSTER AND ADDITIONAL DOSE PFIZER ASTRAZENECA SINOVAC SPUTNIK V JOHNSON & JOHNSON MODERNA COVOVAX COVAXIN SINOPHARM EUA Approval Data Extraction and Synthesis HTAC Recommendation Decision of Secretary of continue reading : Expedited Track (COVID-19 Vaccines)
MEMORANDUM- Request for Comments on Evaluation Framework for COVID-19 Vaccines (Version 2)
HTAC Evaluation Framework for COVID-19 Vaccines 2022 link: bit.ly/HTAC-C19EvalFramework_Version2 Document preview:
Preliminary Recommendation on Tenofovir/Lamivudine/Dolutegravir (TLD)
Document link: MEDICINES RECOMMENDED FOR INCLUSION IN THE PHILIPPINE NATIONAL FORMULARY (PNF) (Proponents may submit appeals to hta@doh.gov.ph until 23 August 2021.) Document Preview:
COVID-19 Vaccine (ChAdOx1-S [recombinant]) (COVID-19 Vaccine AstraZeneca) for the prevention of COVID-19 (June Reassessment)
Date of publication: June 25, 2021 Decision of the Secretary of Health: Approved Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of continue reading : COVID-19 Vaccine (ChAdOx1-S [recombinant]) (COVID-19 Vaccine AstraZeneca) for the prevention of COVID-19 (June Reassessment)